Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)

(2010) Bernard Charbonnel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes

(2009) Mozhgan Dorkhan et al.   Cardiovascular Diabetology

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)

(2009) A. J. Scheen et al.   DIABETIC MEDICINE

A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats

(2009) Kim Henriksen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Thiazolidinediones and clinical outcomes in type 2 diabetes

(2009) Ravi Retnakaran et al.   LANCET

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study

(2009) Ian J. Douglas et al.   PLOS MEDICINE

Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress

(2008) Nobuo Cho et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone

(2008) Philip J. Larsen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Genome-wide profiling of PPAR :RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis

(2008) R. Nielsen et al.   GENES & DEVELOPMENT

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of thiazolidinediones on BMD and osteoporosis

(2008) Allyson K McDonough et al.   Nature clinical practice. Endocrinology & metabolism

Diagnosis of Heart Failure

(2008) Anna Marie Chang et al.   Heart Failure Clinics